Drug intelligence / Profile preview

fosinoprilat

Development stage
Unknown
Lead developer
Bristol Myers Squibb
Modality
Small Molecules
Administration
Oral
01

Overview

Fosinoprilat is the active metabolite of fosinopril, an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension and heart failure. Fosinopril itself is a prodrug that is rapidly hydrolyzed in the body to form fosinoprilat, which exerts its pharmacological effects. Fosinoprilat acts as a competitive inhibitor of ACE, blocking the conversion of angiotensin I to angiotensin II—a potent vasoconstrictor involved in blood pressure regulation and aldosterone secretion. By inhibiting this pathway, fosinoprilat reduces peripheral vascular resistance and lowers blood pressure, while also decreasing afterload on the heart in patients with heart failure[3][5][6]. Unlike some other ACE inhibitors that are eliminated primarily by renal excretion, both renal and hepatic pathways contribute to elimination of fosinopril/fosinoprilat[5].

Other names
fosinoprilat
02

Targets

ACE (Angiotensin Converting Enzyme)

Beyond the preview

Go deeper on fosinoprilat.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fosinoprilat.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call